Saxagliptin tablets 5mg “Sawai” contain saxagliptin hydrate, a dipeptidyl peptidase-4 (DPP-4) inhibitor manufactured by Sawai Pharmaceutical, used to improve glycemic control in adults with type 2 diabetes mellitus. It is available as a 5mg 1 tablet formulation with YJ code 3969017F2032.
Saxagliptin tablets 5mg “Sawai”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
